Aptamer: A potential oligonucleotide nanomedicine in the diagnosis and treatment of hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is one of the most common cancers with a high mortality rate. Late diagnosis and poor prognosis are still a major drawback since curative therapies such as liver resection and liver transplantation are effective only for an early stage HCC. Development of novel molecul...

Descripción completa

Detalles Bibliográficos
Autores principales: Ladju, Rusdina Bte, Pascut, Devis, Massi, Muhammad Nasrum, Tiribelli, Claudio, Sukowati, Caecilia H.C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5788695/
https://www.ncbi.nlm.nih.gov/pubmed/29416827
http://dx.doi.org/10.18632/oncotarget.23359

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5788695/
https://www.ncbi.nlm.nih.gov/pubmed/29416827
http://dx.doi.org/10.18632/oncotarget.23359

Ejemplares similares